Literature DB >> 22178199

Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis.

Carlo Selmi1, Pier Luigi Meroni, M Eric Gershwin.   

Abstract

Primary biliary cirrhosis (PBC) has been often coined a model autoimmune disease based on the homogeneity amongst patients, the frequency and similarity of antimitochondrial antibodies, including the highly directed immune response to pyruvate dehydrogenase (PDC-E2). A significant number of patients with PBC suffer from sicca and amongst these, there are patients who also have classic Sjögren's syndrome. Indeed, both PBC and Sjögren's syndrome are characterized by inflammation of target epithelial elements. Both diseases can be considered on the basis of a number of other related clinical aspects, including proposed unique apoptotic features of the target tissue, the role of secretory IgA, and the frequency with which both diseases overlap with each other. Indeed, PBC may be considered a Sjögren's syndrome of the liver, whereas Sjögren's syndrome can be equally discussed as PBC of the salivary glands. Dissection of the genetic predispositions for both diseases and especially the molecular basis of effector mechanisms, will become critical elements in developing new therapies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178199      PMCID: PMC3568660          DOI: 10.1016/j.jaut.2011.11.005

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  124 in total

Review 1.  Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium.

Authors:  Qianjin Lu; Yves Renaudineau; Seunghee Cha; Gabor Ilei; Wesley H Brooks; Carlo Selmi; Athanasios Tzioufas; Jacques-Olivier Pers; Stefano Bombardieri; M Eric Gershwin; Steffen Gay; Pierre Youinou
Journal:  Autoimmun Rev       Date:  2010-05-07       Impact factor: 9.754

2.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

3.  Immunological aspects of active chronic hepatitis and primary biliary cirrhosis.

Authors:  S Sherlock
Journal:  Acta Gastroenterol Belg       Date:  1968-06       Impact factor: 1.316

Review 4.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

5.  Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases.

Authors:  N Zurgil; R Bakimer; H M Moutsopoulos; A G Tzioufas; P Youinou; D A Isenberg; M Scheinberg; T Kveder; B Rozman; C Luderschmidt
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

6.  Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.

Authors:  Monica Miozzo; Carlo Selmi; Barbara Gentilin; Francesca R Grati; Silvia Sirchia; Sabine Oertelt; Massimo Zuin; M Eric Gershwin; Mauro Podda; Pietro Invernizzi
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

7.  Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden.

Authors:  J Löfgren; G Järnerot; D Danielsson; I Hemdal
Journal:  Scand J Gastroenterol       Date:  1985-06       Impact factor: 2.423

Review 8.  Current concepts: mouse models of Sjögren's syndrome.

Authors:  Tegan N Lavoie; Byung Ha Lee; Cuong Q Nguyen
Journal:  J Biomed Biotechnol       Date:  2010-12-30

9.  A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid.

Authors:  Fumio Sakauchi; Mitsuru Mori; Mikio Zeniya; Gotaro Toda
Journal:  J Epidemiol       Date:  2005-01       Impact factor: 3.211

View more
  43 in total

Review 1.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

Review 2.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

Review 4.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 5.  Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.

Authors:  Elena Generali; Antonio Costanzo; Carlo Mainetti; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

6.  MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis.

Authors:  Tomohiro Katsumi; Masashi Ninomiya; Taketo Nishina; Kei Mizuno; Kyoko Tomita; Hiroaki Haga; Kazuo Okumoto; Takafumi Saito; Tooru Shimosegawa; Yoshiyuki Ueno
Journal:  Lab Invest       Date:  2016-09-26       Impact factor: 5.662

Review 7.  Extrahepatic autoimmune conditions associated with primary biliary cirrhosis.

Authors:  Annarosa Floreani; Irene Franceschet; Nora Cazzagon; Alice Spinazzè; Alessandra Buja; Patrizia Furlan; Vincenzo Baldo; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

8.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30

9.  Human intrahepatic biliary epithelial cells engulf blebs from their apoptotic peers.

Authors:  G-H Rong; G-X Yang; Y Ando; W Zhang; X-S He; P S C Leung; R L Coppel; A A Ansari; R Zhong; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

Review 10.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.